Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator Licenses SpeechDx Dataset to Eli Lilly and Company, Advancing Speech-Based Markers as a Critical Alzheimer's Research Tool
· prnewswire.com · popularity 18/100 · 0 similar stories today · Brain & Neuroscience (Discovery & Research)
Read the original at prnewswire.com →
Summary
Lilly's partnership signals growing industry recognition of AI-driven speech analysis as a path to predicting Alzheimer's disease risk NEW YORK, Oct. 28, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) announces a new collaboration...
Found in: PR Newswire. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 10.